BioMAP technology incorporates primary human cells in systems engineered to capture the complexity of human disease biology in a highly efficient, high-throughput format. This platform enables us to rapidly profile compounds in multiple disease-relevant environments and identify activities that are most relevant to developing safe, effective therapeutics.

We are growing our business by using our BioMAP platform in collaborations with biotech and pharmaceutical partners to identify high-value compounds and improve the productivity of their pipelines in a number of therapeutic areas, and to identify promising candidates for our proprietary development in the areas of inflammation, cardiovascular disease and related indications.